Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, June 25, 2012

Statins May Work Better in Men Than in Women

Talk to your doctor on this one.
http://women.webmd.com/news/20120625/statins-may-work-better-in-men-than-in-women
Women with heart disease may not benefit as much as men with heart disease from taking cholesterol-lowering drugs, a new research analysis suggests.
The review of studies evaluating statins showed that there was a reduction in death in men but not in women. The study concludes that there is no benefit of statins on stroke and all causes of mortality in women.
However, like men, women who had previous cardiovascular disease such as a heart attack, angina, or stroke and took a statin had a lower risk for a second heart attack, so the drugs do have clear benefits for women with heart disease, researchers say.

Statins and Gender

The findings raise new questions about whether true differences exist between men and women in their response to cholesterol-lowering drugs.
Just one-fifth of the participants in the trials were women, and it could be that this was too small to show real benefits.
"I don't really think biological differences between the sexes make women less susceptible to the benefits of using statins," researcher Jose Gutierrez, MD, MPH, of Columbia University, tells WebMD. "But if we want a clear answer to this question it is critical that more women be included in clinical trials."
The analysis included 11 major studies involving more than 43,000 people.
The studies were designed to examine whether statin therapy lowers heart disease and stroke risk in people who have had a previous heart attack, stroke, or other heart-related event.

Fewer Deaths in Men Who Took Statins

Overall, statin use was associated with a similar reduction in recurrent heart attacks in men and women.
Among men, taking statins was associated with a decrease in strokes and death, but the difference was not seen in women.
The study appears in the June 25 issue of the journal Archives of Internal Medicine.
In an accompanying editorial, Fiona Taylor, PhD, and Shah Ebrahim, DM, of the London School of Hygiene and Tropical Medicine, point out that earlier reviews have shown at-risk women to benefit as much as men from the drugs.
They contend that the researchers failed to include relevant studies that would have shown a clear survival benefit associated with statin use in women with heart disease.
"We suggest that statins work just as well in women as in men," they conclude.

Risk, Benefits Unclear in Women

But cardiologist Rita F. Redberg, MD, says it is far from clear that this is the case, because so few women have been included in past clinical trials.
Redberg is director of Women's Cardiovascular Services at the University of California, San Francisco Medical Center, and she was an editor of the new study.
"Although there is a growing interest in personalized medicine, we still lack high-quality data on the largest group of patients in practice -- women," she wrote.

No comments:

Post a Comment